Cafepharma Today

June 12 2025 - BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
BioNTech buys German mRNA vaccine peer CureVac in $1.2B all-stock deal
Medtronic recalls ventilators linked to 2 serious injuries, 1 death
Merck aims to plug dengue fever vaccine gap in US
RFK Jr. names some vaccine critics to key CDC committee after ousting entire panel
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Venture backers inject $25M into Synageva's rare disease platform
Fierce Biotech
Monday, March 21, 2011 - 1:40pm
tags:
venture capital, Synageva, Lysosomal Acid Lipase deficiency
The Genzyme Corporation: Under Pressure for a Lack of Production
Intellectual Property Brief
Monday, March 21, 2011 - 1:37pm
tags:
Genzyme, patents, Fabrazyme, Fabry's disease
Big Pharma executive compensation plans 'flawed' - study
Pharma Times, UK
Monday, March 21, 2011 - 11:58am
tags:
Big Pharma, executive pay
Andrew Witty of GSK: 'Big firms have allowed themselves to be seen as detached from society'
Guardian, UK
Monday, March 21, 2011 - 11:56am
tags:
UK, GSK, Andrew Witty, Pharma CEOs
Mylan Sues U.S. FDA to Block Ranbaxy’s Sale of Lipitor
Bloomberg
Monday, March 21, 2011 - 11:43am
tags:
Mylan, Ranbaxy, FDA, Lipitor, generics
J&J CEO Bill Weldon Has ‘No Plans’ To Retire Now
Pharmalot
Monday, March 21, 2011 - 11:41am
tags:
Pharma CEOs, William Weldon, JNJ
DSM Likely Interested in Pfizer Nutrition Unit, Cheuvreux Says
Bloomberg
Monday, March 21, 2011 - 11:35am
tags:
Royal DSM, Pfizer, M&A
Shire advances rival to Dyax drug
Bizjournals.com
Monday, March 21, 2011 - 11:34am
tags:
Shire, Dyax, hereditary angiodema, Kalbitor, Firazyr
XenoPort announces mid-stage drug study result
Yahoo/AP
Monday, March 21, 2011 - 11:32am
tags:
XenoPort, arbaclofen placarbil, heartburn
Why InterMune's Earnings Aren't So Hot
Motley Fool
Monday, March 21, 2011 - 11:31am
tags:
earnings, InterMune
Roche, Curis Skin Cancer Drug Advances
TheStreet.com
Monday, March 21, 2011 - 11:25am
tags:
skin cancer, Roche, Curis
Ariad Pharmaceuticals: Solid Company but Not a Steal
Seeking Alpha
Monday, March 21, 2011 - 11:24am
tags:
Ariad Pharmaceuticals
Depomed's Recent Events Boost Balance Sheet
Seeking Alpha
Monday, March 21, 2011 - 11:21am
tags:
Depomed, Abbott Laboratories, Gralise, Glumetza
Novartis gets EU approval for oral MS drug
Yahoo/AP
Monday, March 21, 2011 - 11:19am
tags:
Europe, MS, Novartis, multiple sclerosis
To improve drug safety, FDA should check its mixed-up files
Boston Globe, MA
Sunday, March 20, 2011 - 11:33am
tags:
FDA
Klobuchar wants KV drug investigation
bizjournals.com
Sunday, March 20, 2011 - 11:28am
tags:
KV Pharmaceutical, Makena
The Next Big Thing In Biotech: Bristol-Myers (video)
The Street
Sunday, March 20, 2011 - 11:17am
tags:
Bristol-Myers Squibb
Eli Lilly "very much opposed" to merger: CEO
Yahoo/Reuters
Saturday, March 19, 2011 - 11:30am
tags:
Eli Lilly, M&A
Amgen Statement on CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer
Bradenton Herald, FL
Saturday, March 19, 2011 - 11:00am
tags:
Panitumumab, colorectal cancer, Amgen, Vectibix
Cortex Pharmaceuticals (CORX.OB) Shares Surge on Q4, FY2010 Results, Recent Business Highlights Read more: http://www.ibtimes.com/articles/124529/20110318/cortex-pharmaceuticals-corx-ob-shares-surge-on-q4-fy2010-results-recent-business-highlights.htm#i
International Business Times
Saturday, March 19, 2011 - 10:58am
tags:
Cortex Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Vaccine Advice, Vandalized
In the Pipeline
Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.